Health Science Reports is a premier open-access journal published by WILEY, dedicated to advancing knowledge in the diverse field of health sciences. Since its inception in 2018, this journal has provided a vital platform for researchers, professionals, and students to disseminate their work, focusing on a wide array of medical and health-related topics. Recognized for its quality and impact, Health Science Reports has achieved a Q2 ranking in the 2023 category of Medicine (miscellaneous), positioning itself within the 59th percentile of general medicine according to Scopus rankings. The journal aims to bridge the gap between emerging research and practical applications, thereby fostering interdisciplinary collaboration among scientists and practitioners. As an open-access publication, it ensures that cutting-edge research is freely accessible to a global audience, enhancing the visibility of contributions in this critical area of study. With its commitment to rigorous peer review and scholarly excellence, Health Science Reports is poised to become an essential resource for anyone involved in health sciences.

Tropical Diseases Travel Medicine and Vaccines, published by SPRINGERNATURE, stands at the forefront of research in the fields of infectious diseases and public health, with an impressive impact factor that signifies its relevance and influence. Since its inception in 2015, this peer-reviewed journal has maintained an open access policy, ensuring that cutting-edge research on tropical diseases and travel medicine is readily available to researchers, professionals, and students worldwide. The journal currently ranks in the Q2 Quartile for both Infectious Diseases and Public Health, Environmental and Occupational Health, reflecting its substantial contribution to these critical areas of study. With a strong Scopus rank of #176 in Public Health and #138 in Infectious Diseases, it serves as a vital platform for innovative studies that advance understanding and response strategies related to tropical diseases. For its vast audience, Tropical Diseases Travel Medicine and Vaccines not only acts as a bridge connecting researchers with practical applications but also nurtures academic discourse essential for future advancements in global health.

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Infectious Agents and Cancer is a pivotal open access journal published by BMC, dedicated to advancing research at the intersection of infectious diseases and oncology. Since its inception in 2006, this journal has provided a platform for the exploration of the complex relationships between infectious agents and cancer development, aimed at researchers, healthcare professionals, and students alike. With a broad scope encompassing epidemiology and cancer research, the journal holds an impressive ranking in the Q3 quadrant for epidemiology, infectious diseases, and oncology in 2023, while also featuring in the Q4 category for cancer research. This distinguished journal not only contributes to the enrichment of scientific knowledge but also fosters collaborative efforts towards innovative solutions in the fight against cancer. Being part of the UK publishing landscape, the journal is accessible to a global audience, ensuring that vital research findings are disseminated widely to inform policy and practice in health sciences.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

Tropical Biomedicine, published by the Malaysian Society of Parasitology and Tropical Medicine, is an influential journal dedicated to the field of infectious diseases and parasitology. Since its inception in 2005, the journal has aimed to advance scientific knowledge and foster research in tropical health, providing a vital platform for disseminating high-quality research findings, case studies, and reviews. With a Q3 ranking in Infectious Diseases and a Q4 in Parasitology for 2023, the journal plays an essential role in addressing the challenges faced in these fields, particularly in tropical and subtropical regions. Although currently not open access, its contributions are pivotal for researchers, healthcare professionals, and students dedicated to combating diseases prevalent in diverse ecological environments. By focusing on relevant topics and innovative approaches, Tropical Biomedicine seeks to enlighten and inspire the ongoing fight against tropical diseases, ultimately improving public health outcomes.

MEMORIAS DO INSTITUTO OSWALDO CRUZ, published by the esteemed FUNDACO OSWALDO CRUZ in Brazil, serves as a vital platform for the dissemination of research in the fields of medicine and microbiology. With its inception dating back to 1909 as an open-access journal, it has made significant strides in promoting the understanding of health-related topics and infectious diseases across its diverse readership. This journal is recognized for its contribution to the scholarly community, boasting a Q2 category in Medicine (miscellaneous) and a Q3 rating in Microbiology (medical) as per the 2023 quartiles. Located in Rio de Janeiro, the journal not only embraces a rich historical context but also engages with contemporary issues in public health. Researchers and professionals in related fields will find valuable insights and data that underscore the significance of scientific collaboration in tackling global health challenges. With access to its archives spanning multiple decades, MEMORIAS DO INSTITUTO OSWALDO CRUZ remains a key resource for students and researchers alike as they endeavor to expand their knowledge and contribute to future innovations in health science.